SHP: ShangPharma Corporation StockTalks

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Friday, December 21, 2012, 9:10 AM Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.
Losers: ECTE -18%. RIMM -14%. ALU -7%. 1 Comment [On the Move]
Tuesday, November 20, 2012, 6:18 AM ShangPharma (SHP): Q3 EPS of $0.15 misses by $0.05. Revenue of $31.9M (+10.6% Y/Y) misses by $2.1M. (PR) Comment! [Earnings, Healthcare]
Monday, August 20, 2012, 12:23 PM ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report. Comment! [Earnings, Global & FX, Healthcare, On the Move]
Monday, August 20, 2012, 7:44 AM ShangPharma (SHP): Q2 EPS of $0.11 misses by $0.09. Revenue of $31.8M (+15.7% Y/Y) misses by $1M. (PR) Comment! [Earnings, Healthcare]
Friday, July 6, 2012, 8:11 AM Shares of ShangPharma (SHP) move up 15.1% premarket after the firm receives a "going private" buyout offer from a group of private investors at $8.50-$9.50 per ADS. The company says that it's forming a special committee to study the offer. Comment! [M&A, Healthcare]
Friday, August 12, 2011, 11:02 AM Chinese biotech research firm ShangPharma (SHP +18.3%) pops after announcing a $10M stock repurchase program. In addition, founder and CEO Michael Xin Hui intends to purchase up to $1M worth of its shares through a personal, family-owned company. Comment! [Healthcare, Global & FX, On the Move]

SHP ShangPharma Corporation

SHP

ShangPharma Corporation